[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
[2] ZHANG F, ZHUGE YZ, QIU YD, et al.Prognostic accuracy of staging systems in patients with primary liver cancer treated with transarterial chemoembolization[J].J Clin Hepatol, 2011, 27 (4) :378-381. (in Chinese) 张峰, 诸葛宇征, 仇毓东, 等.肝癌分期对肝动脉化疗栓塞术后生存的预测作用[J].临床肝胆病杂志, 2011, 27 (4) :378-381.
|
[3]DINDO D, DEMARTINES N, CLAVIEN PA.Classification of surgical complications:a new proposal with evaluation in a cohort of6336 patients and results of a survey[J].Ann Surg, 2004, 240 (2) :205-213.
|
[4]GUO Z, XIANG BD, JIANG JH, et al.Survival comparison between hepatic resection and transarterial chemoembolization for matched patients with large hepatocellular carcinoma[J].Chin J Gen Surg, 2015, 30 (4) :290-293. (in Chinese) 郭哲, 向邦德, 姜经航, 等.肝切除与肝动脉化疗栓塞治疗大肝癌的疗效比较[J].中华普通外科杂志, 2015, 30 (4) :290-293.
|
[5]LIU YY, LIU XX.International controversy in partial hepatectomy for patients in stage B or C of Barcelona Clinic Liver Cancer[J].Chin J Dig Surg, 2015, 14 (8) :609-611. (in Chinese) 刘允怡, 刘晓欣.巴塞罗那临床肝癌B期和C期患者施行部分肝切除术治疗的国际争议[J].中华消化外科杂志, 2015, 14 (8) :609-611.
|
[6]LIU X, LI LQ, XIANG BD, et al.Efficacy of hepatic resection and transarterial chemoembolization for stage B hepatocellular carcinoma in the barcelona clinic liver cancer classification[J].Chin J Clin Oncol, 2012, 39 (16) :1225-1228. (in Chinese) 刘星, 黎乐群, 向邦德, 等.巴塞罗那肝癌临床分期B期肝细胞性肝癌手术与TACE疗效比较[J].中国肿瘤临床, 2012, 39 (16) :1225-1228.
|
[7]WU K, YANG XH, WANG JP.Risk factors for liver injury after liver cancer surgery in elderly patients[J].Chongqing Med, 2014, 43 (25) :3365-3367. (in Chinese) 吴凯, 杨晓辉, 王建平.老年患者肝癌术后肝损伤的相关因素分析[J].重庆医学, 2014, 43 (25) :3365-3367.
|
[8] WU FX, ZHANG YQ, XIANG BD, et al.Hepatic resection versus transaterial chemoembolization for BCLC stage B Child-Pugh A HCCpatients[J].Chin J Hepatobiliary Surg, 2013, 19 (1) :23-28. (in Chinese) 吴飞翔, 张涌泉, 向邦德, 等.巴塞罗那分期B期肝功能ChildPugh A级肝细胞癌患者手术与经肝动脉化疗栓塞疗效的比较[J].中华肝胆外科杂志, 2013, 19 (1) :23-28.
|
[9]ZHONG JH, QI LN.Hepatectomy brings good survival benefits to patients with BCLC stage B/C hepatocellular carcinoma[J].Chin JOncol Prev Treat, 2013, 30 (4) :377-377. (in Chinese) 钟鉴宏, 齐鲁楠.肝切除术治疗BCLC-B期/C期肝细胞性肝癌患者的生存获益较佳[J].中国癌症防治杂志, 2013, 30 (4) :377-377.
|
[10]MA L, LIU W, ZHONG JH, et al.A comparison of survival in hepatocellular carcinoma patients with BCLC stage B and C between hepatic resection and transarterial chemoembolization[J].Guangx Med J, 2012, 34 (8) :963-965. (in Chinese) 马良, 刘玮, 钟鉴宏, 等.手术与经肝动脉导管化疗栓塞治疗中晚期肝癌生存率的比较[J].广西医学, 2012, 34 (8) :963-965.
|
[11]ZHAO WC, YANG N, ZHU N, et al.Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria[J].World J Surg, 2012, 36 (8) :1811-1823.
|
[12]LIN CT, HSU KF, CHEN TW, et al.Comparing hepatic resection and transarterial chemoembolization for Barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma:change for treatment o choice?[J].World J Surg, 2010, 34 (9) :2155-2161.
|
[13]YIN L, LI H, LI AJ, et al.Partial hepatectomy vs transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria:a RCT[J].J Hepatol, 2014, 61 (1) :82-88.
|
[14] XIA HT, GUO GH, HUANG XQ, et al.Variations in serum level o cytokines associated with vascular endothelial cells before and after treatment with either TACE or liver resection in patients with hepatocellular carcinoma[J].Chin J Hepatobiliary Surg, 2012, 18 (18) :23-26. (in Chinese) 夏红天, 郭广宏, 黄晓强, 等.肝动脉化疗栓塞前后血管内皮细胞相关细胞因子的变化[J].中华肝胆外科杂志, 2012, 18 (18) :23-26.
|
[15]MARELLI L, STIGLIANO R, TRIANTOS C, et al.Transarteria therapy for hepatocellular carcinoma:which technique is more effective?A systematic review of cohort and randomized studies[J].Cardiovasc Intervent Radiol, 2007, 30 (1) :6-25.
|